Lexeo Therapeutics Announces Public Offering Amid Stock Price Decline

Lexeo Therapeutics has announced a public offering and private placement to raise capital for its innovative therapies, despite a decline in its stock price following the announcement. This dual approach reflects the company's growth potential and commitment to advancing research and development, although it raises concerns about share dilution among investors.